Craig D Platt1, Janet Chou1, Patrick Houlihan2, Yousef R Badran1, Lalit Kumar1, Wayne Bainter1, P Luigi Poliani3, Carlos J Perez4, Sharon Y R Dent4, David E Clapham5, Fernando Benavides4, Raif S Geha6. 1. Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass. 2. Department of Cardiology, Boston Children's Hospital, Boston, Mass. 3. Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. 4. Department of Epigenetics and Molecular Carcinogenesis, University of Texas M. D. Anderson Cancer Center, Smithville, and the Graduate School of Biomedical Sciences at Houston, Houston, Tex. 5. Department of Cardiology, Boston Children's Hospital, Boston, Mass; Howard Hughes Medical Institute, Chevy Chase, Md. 6. Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass. Electronic address: raif.geha@childrens.harvard.edu.
Abstract
BACKGROUND: Leucine-rich repeat containing 8A (LRRC8A) is an ubiquitously expressed transmembrane protein with 17 leucine-rich repeats (LRRs) at its C-terminal end and is an essential component of the volume-regulated anion channel (VRAC), which controls cellular volume. A heterozygous mutation in LRRC8A that truncates the 2 terminal LRRs was reported in a patient with agammaglobulinemia and absent B cells and was demonstrated to exert a dominant negative effect on T- and B-cell development in mice. Lrrc8a-/- mice have severely defective T-cell development and function. It is not known whether the T- and B-cell defects caused by LRRC8A deficiency are caused by loss of VRAC activity. OBJECTIVE: We sought to determine whether VRAC activity is required for normal T-cell development and function. METHODS: VRAC activity was examined by using patch-clamp analysis. Flow cytometry was used to examine T-cell development. T-cell proliferation, cytokine secretion, and antibody titers were measured by using standard techniques. RESULTS: We demonstrate that the spontaneous mouse mutant ébouriffé (ebo/ebo) harbors a homozygous 2-bp frameshift mutation in Lrrc8a that truncates the 15 terminal LRRs of LRRC8A. The Lrrc8aebo mutation does not affect protein expression but drastically diminishes VRAC activity in T cells. ebo/ebo mice share features with Lrrc8a-/- mice that include curly hair, infertility, reduced longevity, and kidney abnormalities. However, in contrast to Lrrc8a-/- mice, ebo/ebo mice have normal T-cell development and function and intact antibody response to T-dependent antigen. CONCLUSION: LRRC8A-dependent VRAC activity is dispensable for T-cell development and function.
BACKGROUND:Leucine-rich repeat containing 8A (LRRC8A) is an ubiquitously expressed transmembrane protein with 17 leucine-rich repeats (LRRs) at its C-terminal end and is an essential component of the volume-regulated anion channel (VRAC), which controls cellular volume. A heterozygous mutation in LRRC8A that truncates the 2 terminal LRRs was reported in a patient with agammaglobulinemia and absent B cells and was demonstrated to exert a dominant negative effect on T- and B-cell development in mice. Lrrc8a-/- mice have severely defective T-cell development and function. It is not known whether the T- and B-cell defects caused by LRRC8A deficiency are caused by loss of VRAC activity. OBJECTIVE: We sought to determine whether VRAC activity is required for normal T-cell development and function. METHODS:VRAC activity was examined by using patch-clamp analysis. Flow cytometry was used to examine T-cell development. T-cell proliferation, cytokine secretion, and antibody titers were measured by using standard techniques. RESULTS: We demonstrate that the spontaneous mouse mutant ébouriffé (ebo/ebo) harbors a homozygous 2-bp frameshift mutation in Lrrc8a that truncates the 15 terminal LRRs of LRRC8A. The Lrrc8aebo mutation does not affect protein expression but drastically diminishes VRAC activity in T cells. ebo/ebomice share features with Lrrc8a-/- mice that include curly hair, infertility, reduced longevity, and kidney abnormalities. However, in contrast to Lrrc8a-/- mice, ebo/ebomice have normal T-cell development and function and intact antibody response to T-dependent antigen. CONCLUSION:LRRC8A-dependent VRAC activity is dispensable for T-cell development and function.
Authors: Ruhma Syeda; Zhaozhu Qiu; Adrienne E Dubin; Swetha E Murthy; Maria N Florendo; Daniel E Mason; Jayanti Mathur; Stuart M Cahalan; Eric C Peters; Mauricio Montal; Ardem Patapoutian Journal: Cell Date: 2016-01-28 Impact factor: 41.582
Authors: Felizia K Voss; Florian Ullrich; Jonas Münch; Katina Lazarow; Darius Lutter; Nancy Mah; Miguel A Andrade-Navarro; Jens P von Kries; Tobias Stauber; Thomas J Jentsch Journal: Science Date: 2014-04-10 Impact factor: 47.728
Authors: Lalit Kumar; Janet Chou; Christina S K Yee; Arturo Borzutzky; Elisabeth H Vollmann; Ulrich H von Andrian; Shin-Young Park; Georg Hollander; John P Manis; P Luigi Poliani; Raif S Geha Journal: J Exp Med Date: 2014-04-21 Impact factor: 14.307
Authors: Axel R Concepcion; Larry E Wagner; Jingjie Zhu; Anthony Y Tao; Jun Yang; Alireza Khodadadi-Jamayran; Yin-Hu Wang; Menghan Liu; Rebecca E Rose; Drew R Jones; William A Coetzee; David I Yule; Stefan Feske Journal: Nat Immunol Date: 2022-02-01 Impact factor: 31.250
Authors: Philippe Behe; Juliet R Foote; Adam P Levine; Craig D Platt; Janet Chou; Fernando Benavides; Raif S Geha; Anthony W Segal Journal: Front Pharmacol Date: 2017-05-12 Impact factor: 5.810